npm1 mutated acute myeloid leukaemia
Published 3 weeks ago • 106 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
1:38
value of mrd in patients with npm1-mutated aml
-
4:43
treatment of npm1-mutated aml: intensive standard treatment
-
1:45
the impact of secondary-type mutations in npm1-mutated aml
-
1:41
the emerging role of menin inhibitors in the treatment of npm1-mutated and kmt2a-rearranged r/r aml
-
3:18
the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
-
15:01
understanding acute myeloid leukemia with npm1 mutation: a comprehensive guide
-
0:30
symptoms of leukemia
-
0:59
menin inhibitors in aml: providing options for patients with npm1 mutation and kmt2a rearrangement
-
2:51
komet-008: a phase i trial of ziftomenib combinations in kmt2a-rearranged or npm1-mutant aml
-
3:23
the prognostic value of idh1 and idh2 in acute myeloid leukemia (aml)
-
1:44
new targets to treat acute myeloid leukemia (aml) with flt3 mutations
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
1:51
case review: idh2-mutated acute myeloid leukemia
-
1:56
ngs vs flow cytometry for mrd assessment in npm1-mutated aml
-
1:38
lba: komet-001 - ziftomenib monotherapy in r/r npm1-mutated aml
-
4:34
the genetics of acute myeloid leukemia (aml)
-
3:21
the prognostic impact of flt3-itd and flt3-tkd in npm1-mutated aml
-
4:51
the impact of idh mutated clones in npm1 aml